Proteins
Delivering research to GMP-grade proteins with exceptional batch-to-batch consistency and pharmacopeia-compliant manufacturing. Our multi-tiered product portfolio ensures >95% purity, controlled endotoxin levels (<1.0 EU/µg), and comprehensive CoA documentation meeting global regulatory requirements.
Learn More
QVirus™
ICDMO provides high-titer viral vector packaging solutions, ensuring efficient gene delivery across diverse cell types, from custom designs to large-scale production, streamlining your path from research to industrial production.
Learn More
RNA
With expertise in GMP-grade synthesis, innovative delivery systems (liposomes, LNPs, exosomes), and comprehensive CMC support, ICDMO optimizes every step of your RNA drug development pathway.
Learn More
CDMO
ICDMO pioneers breakthrough solutions in biopharmaceutical development. Our deep expertise empowers partners to transform innovative therapies from concept to commercialization, accelerating next-generation biologics, gene therapies, and vaccines to market.
Learn More
Gene Editing
Accelerate your discoveries with our comprehensive portfolio of cell lines and animal models. Choose from ready-made knockout/knockin options or let our expert team create custom genetic modifications tailored to your needs.
Learn More
Microbiology
Master microbial fermentation from bench to commercial scale with our integrated platform. ICDMO's cGMP-certified facilities combine advanced strain engineering with robust production capabilities, delivering optimized yields for your research and industrial applications.
Learn Moreservices
products
platforms
Cell Line Service
Viral Service
MicroRNA Service
Nucleotides Service
RNAi Service
Microbe Service
Libraries Construction
Drug Discovery
In the area of stable cell line generation, decades of experience with cell culture optimization and exclusive expression vectors allow for the quick and dependable creation of customized cell lines for applications such as gene knockdown, protein expression, and genome editing.
Stable cell lines with specific gene over-expression or knock-down are very helpful in gene function analysis, target discovery, target validation, assay development, and compound...
ICDMO provides world-class packaging services for a variety of viral types using our Qvirus™ platform. Our state-of-the-art facilities and highly...
MicroRNAs comprise a novel class of endogenous, small (only about 20 to 25 nucleotides), and noncoding RNAs, and almost involved in the physiologic and pathologic process...
ICDMO has built-up leading scientific, technical and commercial track records, successfully advancing therapeutic programs for numerous major industry and academic...
Our portfolio includes 500+ validated drug targets across membrane receptors, immune checkpoints, enzymes, and nuclear regulators. Each protein ensures consistent quality through...
CRISPR/Cas9 PlatformCB owned by ICDMO performs gene knockout/knockin program with the CRISPR/Cas9 system, from designing gRNA constructs to transfection and single clone generation of a wide range of cells, including difficult-to-transfect and tumor cell lines, as well as plants, mouse and other animal models.
Learn More
From many years of groundbreaking work with virus vector design to the latest gene therapy technology support, our Qvirus™ Platform offers a comprehensive portfolio of services for the efficient design, development, manufacturing, and analytical testing of virus vector products.
Learn More
Complete solutions are provided for RNA discovery, expression analysis, functional research, and mechanism analysis. Our next-generation sequencing and microarray platforms enable researchers to explore the world of RNA on an unprecedented scale and map all RNAs involved in cell life programs, human diseases, and drug discovery.
Learn More
We are fully engaged in developing unique technologies to facilitate the investigation of microbial research. Our high-quality products and services include microbial genome editing, identification, sequencing, proteomics, and metabolomics. We possess a mature fermentation platform consisting of large fermentation tanks, bioreactors, and large-scale purification systems.
Learn More
The one-stop zebrafish R&D service platform delivers reliable, cost-effective solutions across drug development, toxicity testing, and basic research, harnessing the unique advantages of zebrafish models to accelerate discovery and ensure high-quality results.
Learn More
CRISPR/Cas9 PlatformCB
QvirusTM Platform
IntegrateRNATM Platform
Microbiology Platform
Zebrafish Platform
Fast proposals, regular updates, detailed reports.
Strict quality control and contamination-free results.
